Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06344338

Application of tDCS Stimulation in Controlling Refractory Status Epilepticus

Application of Targeting Transcranial Direct Current Stimulation (tDCS) Stimulation in the Treatment of Refractory Status Epilepticus

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
32 (estimated)
Sponsor
Xuanwu Hospital, Beijing · Academic / Other
Sex
All
Age
14 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The purpose of the study is to assess the efficacy and safety of targeting tDCS stimulation for treatment of Refractory status epilepticus

Detailed description

After being informed about the study and potential risks, the recruited patients, giving written informed consent, will be determined of the eligibility for study entry. The patients who meet the eligibility requirements will be randomized in a 1:1 ratio to undergo targeting tDCS stimulation (up to 10 times) or sham stimulation.

Conditions

Interventions

TypeNameDescription
DEVICEtDCS stimulationIn the real-stimulation group, Treatment was for 20 min, repeated twice in a day, then again over the next few days. The maximum number of stimuli required to terminate the status epilepticus should not exceed 10. In the sham-stimulation group, The duration and frequency of tDCS are the same as those in the treatment group, but the tDCS device is not active during the 20 minutes of sham-stimulation
DEVICETDCS sham-stimulationTDCS sham-stimulation

Timeline

Start date
2024-04-01
Primary completion
2024-12-31
Completion
2025-03-31
First posted
2024-04-03
Last updated
2024-07-31

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06344338. Inclusion in this directory is not an endorsement.